Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in VIR — Vir Biotechnology, Inc.

CIK 1137774 NEWARK, NJ
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,281,005
+$247,004 QoQ
Shares Held
125,712
+8.9% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 237 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. VIR ranks #62 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 130,659 $81,471,112
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 133,294 $66,211,127
3 BMRN
Biomarin Pharmaceutical Inc
 392,811 $22,476,644
4 INCY
Incyte Corp
 191,312 $21,687,128
5 CYTK
Cytokinetics Inc
 214,535 $18,276,236
6 LGND
Ligand Pharmaceuticals Inc
 54,623 $17,265,784
7 PTCT
Ptc Therapeutics, Inc.
 185,820 $15,157,337
8 MRVI
Maravai Lifesciences Holdings, Inc.
 2,152,154 $13,429,440

All Filings in VIR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,281,005 125,712
2026-03-31 $1,034,001 115,402
2025-12-31 $1,697,698 281,542
2025-09-30 $1,440,827 252,334
2025-06-30 $3,076,678 610,452
2025-03-31 $4,333,752 668,789
2024-12-31 $1,795,136 244,569
2024-09-30 $3,186,013 425,369
2024-06-30 $2,590,514 291,069
2024-03-31 $1,445,844 142,729
2023-12-31 $4,682,819 465,489
2023-09-30 $2,924,086 312,069
2023-06-30 $5,210,515 212,414
2023-03-31 $5,097,340 219,052
2022-12-31 $6,535,598 258,222
2022-09-30 $5,026,623 260,717
2022-06-30 $3,724,019 146,212
2022-03-31 $1,637,258 63,657
2021-12-31 $451,149 10,775
2021-09-30 $276,569 6,355
2021-06-30 $228,126 4,825
2021-03-31 $234,047 4,565